Report Detail
Global Anticoagulants Market Research Report 2012-2024
- RnM3567247 |
- 01 July, 2019 |
- Global |
- 95 Pages |
- HeyReport |
- Other
Summary
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulants market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bayer
Sanofi
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
VTE
ACS/MI
AF
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 Platelet aggregation inhibitors (PAI)
- 1.2.1.2 Low-molecular-weight Heparin (LMWH)
- 1.2.1.3 Direct thrombin inhibitor (DTI)
- 1.2.1.4 Direct factor Xa inhibitors (DFXa)
- 1.2.1.5 Vitamin K antagonists (VKA)
- 1.2.1.6 Others
- 1.2.2 by Application
- 1.2.2.1 VTE
- 1.2.2.2 ACS/MI
- 1.2.2.3 AF
- 1.2.2.4 Others
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 Platelet aggregation inhibitors (PAI) Market, 2013-2018
- 4.1.2 Low-molecular-weight Heparin (LMWH) Market, 2013-2018
- 4.1.3 Direct thrombin inhibitor (DTI) Market, 2013-2018
- 4.1.4 Direct factor Xa inhibitors (DFXa) Market, 2013-2018
- 4.1.5 Vitamin K antagonists (VKA) Market, 2013-2018
- 4.1.6 Others Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 Platelet aggregation inhibitors (PAI) Market Forecast, 2019-2024
- 4.2.2 Low-molecular-weight Heparin (LMWH) Market Forecast, 2019-2024
- 4.2.3 Direct thrombin inhibitor (DTI) Market Forecast, 2019-2024
- 4.2.4 Direct factor Xa inhibitors (DFXa) Market Forecast, 2019-2024
- 4.2.5 Vitamin K antagonists (VKA) Market Forecast, 2019-2024
- 4.2.6 Others Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 VTE Market, 2013-2018
- 5.1.2 ACS/MI Market, 2013-2018
- 5.1.3 AF Market, 2013-2018
- 5.1.4 Others Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 VTE Market Forecast, 2019-2024
- 5.2.2 ACS/MI Market Forecast, 2019-2024
- 5.2.3 AF Market Forecast, 2019-2024
- 5.2.4 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 Bayer
- 8.2 Sanofi
- 8.3 Boehringer Ingelheim
- 8.4 Johnson & Johnson
- 8.5 Genentech (Roche)
- 8.6 AstraZeneca
- 8.7 Bristol-Myers Squibb
- 8.8 Aspen
- 8.9 Lilly
- 8.10 Otsuka
- 8.11 Pfizer
- 8.12 Daiichi Sankyo
- 8.13 The Medicines Company
9 Conclusion
Summary:
Get latest Market Research Reports on Global Anticoagulants . Industry analysis & Market Report on Global Anticoagulants is a syndicated market report, published as Global Anticoagulants Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of Global Anticoagulants market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
